its subsidiaries have invested in a Research & Development center and new factory in India and invested in machinery and equipment for replacements and improvement of production capacity and efficiency

November 8, 2017) for a period of not more than 2 years from the first draw down date with additional in mortgage value for the same Land, Building, and Machinery Mortgaged in order to use the fund as

as of November 8, 2017) for a period of not more than 2 years from the first draw down date with additional in mortgage value for the same Land, Building, and Machinery Mortgaged in order to use the

equipment dropped by 38.46% QoQ due to decrease in demand on products. • Other revenues comprise of revenue from sale of scrap and zinc and machinery rental. Cost of Goods Sold • Cost to revenue from

sales and services of the Company increased from Baht 1,449.23 million to Baht 1,525.25 million, increased by Baht 76.02 million or 5.25% due to direct labor and production overhead increases. Selling and

million, increased by Baht 45 million or 13% due to direct labor and production overhead increases. Selling and Administrative Expenses In the three-month period ended 31 March 2018 and 2017, total selling

to the invested in Research & Development center in India and new factory in India and Thailand. Moreover, we will keep on investing in machinery and equipment for improving the capacity and efficiency

, upgrading technology in order to increase output of HDI products and the unexpected appreciation of the THB against foreign currencies, which had the effect of a decline in sales revenue, a low production

of the acquisition of Modern Pharma Company Limited Board of Directors' opinion The meeting of shareholders should consider approving to expand the business to cover the production of human and animals

Group, which will allow the Company to extend its power and utility production business which makes use of other different fuels. Furthermore, the transaction will promote investment in order to bring